Brain dysfunction from liver disease affects far more patients than transplant systems recognize, creating a care gap that leaves thousands undertreated despite debilitating cognitive symptoms. The condition progresses along a spectrum from subtle confusion to coma, yet current organ allocation protocols fail to capture this neurological burden adequately. The American College of Gastroenterology has released comprehensive management guidelines addressing hepatic encephalopathy, a neuropsychiatric complication affecting up to 80% of cirrhosis patients. The 24 evidence-based recommendations cover diagnostic approaches, treatment protocols, and prevention strategies using systematic evidence review methodology. The guidelines emphasize identifying covert cases through specialized cognitive testing, as these patients experience significant quality-of-life impairment despite appearing neurologically normal on routine examination. This represents a critical shift toward recognizing hepatic encephalopathy as a systemic disorder requiring proactive management rather than reactive crisis intervention. The recommendations arrive as hepatic encephalopathy becomes increasingly recognized as an independent predictor of mortality and hospitalization risk in liver disease. Previous approaches often waited for obvious neurological symptoms before intervention, missing opportunities for early treatment that could preserve cognitive function and prevent emergency hospitalizations. The guidelines also address the complex interplay between gut bacteria, ammonia metabolism, and brain function that drives the condition. For the growing population of adults with fatty liver disease and alcohol-related liver damage, these protocols offer a structured approach to monitoring and managing one of cirrhosis's most quality-of-life-limiting complications, potentially improving outcomes before transplant becomes necessary.